000 03142nam a22004337a 4500
008 240807s20242024 xxu||||| |||| 00| 0 eng d
022 _a0256-7040
024 _a10.1007/s00381-024-06413-9 [pii]
040 _aOvid MEDLINE(R)
099 _a38702518
245 _aThe role of focused ultrasound for pediatric brain tumors: current insights and future implications on treatment strategies.
251 _aChilds Nervous System. 2024 May 03
252 _aChilds Nerv Syst. 2024 May 03
253 _aChild's nervous system : ChNS : official journal of the International Society for Pediatric Neurosurgery
260 _c2024
260 _fFY2024
260 _p2024 May 03
265 _saheadofprint
265 _tPublisher
266 _d2024-08-07
266 _z2024/05/03 23:29
520 _aCONCLUSION: Discussions regarding future applications of FUS for the treatment of gliomas include improved drug delivery, immunomodulation, radiosensitization, and other technological advancements. Copyright © 2024. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
520 _aINTRODUCTION: Focused ultrasound (FUS) is an innovative and emerging technology for the treatment of adult and pediatric brain tumors and illustrates the intersection of various specialized fields, including neurosurgery, neuro-oncology, radiation oncology, and biomedical engineering.
520 _aMETHODS: The fundamental principles of FUS include its ability to induce thermal ablation or enhance drug delivery through transient blood-brain barrier (BBB) disruption, emphasizing the adaptability of high-intensity focused ultrasound (HIFU) and low-intensity focused ultrasound (LIFU) applications.
520 _aOBJECTIVE: The authors provide a comprehensive overview of the application and implications of FUS in treating pediatric brain tumors, with a special focus on pediatric low-grade gliomas (pLGGs) and the evolving landscape of this technology and its clinical utility.
520 _aRESULTS: Several ongoing clinical trials explore the potential of FUS in offering alternative therapeutic strategies for pathologies where conventional treatments fall short, specifically centrally-located benign CNS tumors and diffuse intrinsic pontine glioma (DIPG). A case illustration involving the use of HIFU for pilocytic astrocytoma is presented.
546 _aEnglish
650 _aIN PROCESS -- NOT YET INDEXED
650 _zAutomated
656 _aMedStar Georgetown University Hospital/MedStar Washington Hospital Center
656 _aNeurosurgery Residency
657 _aJournal Article
700 _aChesney, Kelsi
_bMGUH
_cNeurosurgery Residency
_dMD
700 _aKeating, Gregory
_bMGUH
_cNeurosurgery Residency
_dMD
700 _aPatel, Nirali
_bMGUH
_cNeurosurgery Residency
_dMD
790 _aChesney KM, Keating GF, Patel N, Kilburn L, Fonseca A, Wu CC, Nazarian J, Packer RJ, Donoho DA, Oluigbo C, Myseros JS, Keating RF, Syed HR
856 _uhttps://dx.doi.org/10.1007/s00381-024-06413-9
_zhttps://dx.doi.org/10.1007/s00381-024-06413-9
942 _cART
_dArticle
999 _c14441
_d14441